Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First patient enrolled on clinical study for denosumab biosimilar

europeanpharmaceuticalreview July 24, 2019

Tag: Osteoporosis , Denosumab , biosimilar , Postmenopausal

PharmaSources Customer Service